Hyalone®
Trade name:
Cod ATC:
Active substance:
Dosage:
Manufacturer
Therapeutic indications:
Hyalone® is a temporary synovial fluid replacement for patients with degenerative or mechanical arthropathy without active synovitis.
Description:
Hyalone® contains high molecular weight hyaluronic acid, which is a natural polymer of glycosaminoglycan occurring in the joint cartilage and synovial fluid.
Hyalone® effectively and long-lasting reduces pain and improves joint mobility. A single intra-articular injection relieves pain for up to 12 months, significantly reduces algodysfunctional parameters and the consumption of non-steroidal anti-inflammatory medicines, thus improving the quality of life.
Pharmacovigilance
Information about drug safety
Pharmacovigilance is the science and activities related to the detection, evaluation, understanding and prevention of adverse effects or any other problem related to medicines.
